Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies Tesidolumab, identified as LFG316, and with the CAS number 1531594-08-7, represents a valuable investigational instrument for advancing immune research. The protein primarily interacts with a specific target linked to autoimmune responses, making it to functi… Read More

Camrelizumab, initially known as SHR-1210, represents a significant advancement in tumor treatment, functioning as a monoclonal that inhibits the programmed PD-1 receptor. This checkpoint protein, expressed on lymphocytes , normally suppresses tumor-fighting immune responses, allowing malignant tissues to evade recognition by the body’s immune s… Read More